LC Method Lead — Analytical Development Scientist II

Biogen, Inc.; Cambridge (MA); On-site; USD 117,000 - 157,000; Full time

Benefits offered by this job

Medical Insurance

Dental Insurance

Vision Insurance

Life Insurance

Fitness reimbursement

Disability Insurance

Paid vacation

Holidays

Parental Leave

401(k) matching

Employee stock purchase plan

Tuition reimbursement

Employee Resource Groups

Job summary

Biogen in Cambridge, MA seeks a Scientist II to join Analytical Development as an LC SME and Analytical Project Lead. You will drive LC method development and stability-indicating methods for synthetic drug substances and products, partnering with CMC, formulation, and quality teams.

Leading analytical activities across development programs, you will mentor others, support CDMO oversight, and contribute to future modalities like oligonucleotides and peptides.

Qualifications

• Ph.D./MS/BS in a pharmaceutical/biotech field with relevant LC experience.
• Deep expertise in small molecule LC method development and LC-MS familiarity.
• Experience leading analytical activities in GMP/GLP environments.

Responsibilities

• Serve as LC SME, lead method development, optimization, qualification, troubleshooting.
• Develop stability-indicating methods for synthetic drug substances/products.
• Provide analytical strategy input across development programs from early to late stage.
• Collaborate with CMC, formulation, process development and quality teams.
• Oversee analytical activities at CDMOs, including method transfer and lifecycle management.
• Mentor and share knowledge to build analytical capability.

Skills

LC method development

HPLC/UHPLC

LC-MS

Analytical leadership

GMP/GLP experience

ICH guidelines

Problem solving

Communication

Cross-functional collaboration

Education

Ph.D. with 0–3 years

MS with 4+ years

BS with 6+ years

Job description

Biogen in Cambridge, MA seeks a Scientist II to join Analytical Development as an LC SME and Analytical Project Lead. You will drive LC method development and stability-indicating methods for synthetic drug substances and products, partnering with CMC, formulation, and quality teams.

Leading analytical activities across development programs, you will mentor others, support CDMO oversight, and contribute to future modalities like oligonucleotides and peptides.